In the latest trading session,, 3.66 million Johnson & Johnson (NYSE:JNJ) shares changed hands as the company’s beta touched 0.54. With the company’s most recent per share price at $145.92 changed hands at -$1.67 or -1.13% at last look, the market valuation stands at $351.48B. JNJ’s current price is a discount, trading about -20.59% off its 52-week high of $175.97. The share price had its 52-week low at $144.95, which suggests the last value was 0.66% up since then. When we look at Johnson & Johnson’s average trading volume, we note the 3-month average coming to 7.21 million.
Johnson & Johnson (NYSE:JNJ) trade information
Instantly JNJ was in red as seen in intraday trades today. With action -4.18%, the performance over the past five days has been red. The drop to weekly highs of 151.82 subtracted -1.13% to the stock’s daily price. The company’s shares are showing year-to-date downside of -6.90%, with the 5-day performance at -4.18% in the red. However, in the 30-day time frame, Johnson & Johnson (NYSE:JNJ) is -7.75% down. Looking at the short shares, we see there were N/A shares sold at short interest cover period of N/A days.
Johnson & Johnson (JNJ) estimates and forecasts
Data shows that the Johnson & Johnson share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -6.97% over the past 6 months, a 7.46% in annual growth rate that is considerably higher than the industry average of 3.90%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Johnson & Johnson will rise 9.50%, while the growth in revenue is estimated to hit 6.60% for the next quarter. Year-over-year growth is forecast to reach 3.80% up from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of $21.4 billion. 14 analysts are of the opinion that Johnson & Johnson’s revenue for the quarter ending Jun 2024 will be $22.34 billion. The company’s revenue for the corresponding quarters a year ago was $24.75 billion and $25.53 billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -13.50%. The estimates for the next quarter sales put growth at -12.50%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -0.27%. The 2024 estimates are for Johnson & Johnson earnings to increase by 7.46%, but the outlook for the next 5-year period is at 4.80% per year.
JNJ Dividends
Johnson & Johnson is expected to release its next quarterly earnings report in May. The 3.26% annual yield figure for the share gives it an annual dividend of 4.76. It is important to note, however, that the 3.26% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.
